See our roundup of today's AIM risers - see the full LSE winners & losers board here.
Serica Energy Receives OFAC License And Assurance For UK North Sea Rhum Field
Serica Energy (SQZ) rose over 30% this morning to 101p a share following the US Office of Foreign Assets (OFAC) providing an assurance that non-U.S. entities providing goods, services and support involving Rhum will not be exposed to U.S. secondary sanctions.
These OFAC actions will enable production from the Rhum field to continue unaffected.
Mitch Flegg, Chief Executive of Serica Energy, commented: "The receipt of the License and assurance from OFAC is an important step towards ensuring the integrity of ongoing operations from this important North Sea field which makes a significant contribution to UK indigenous gas production.”
Read more here & follow SQZ here:
Edenville Energy Signs Coal Supply Contract In East Africa
Edenville Energy (EDL) rose 11% this morning to 0.295p a share following the announcement it signed a significant contract for the supply of a specialised coal product to an industrial group in East Africa.
The contract duration is initially for two years for the supply of 3500 tonnes of coal per month with an option to increase this up to 6000 tonnes per month.
Commenting, Rufus Short, CEO of Edenville said: “With this contract, we now have in excess of 8,000 tonnes per month of regular orders and are busy implementing the expansion plans at site. I look forward to providing further updates on the progress of the operation as we continue to establish the project as a significant supplier of coal in East Africa."
Read more here & follow EDL here:
Bacanora Minerals Rises over 8%
Bacanora Minerals (BCN) rose over 8% this morning to 33.25p a share
The company is a London and Canadian listed lithium exploration and development company operations in Mexico and Germany.
The Sonora Lithium Project in Mexico has positive economies and favourable operating costs for a 35,000 tonne per annum battery grade lithium carbonate operation, with an internal rate of return of 26.1% and a US$1.253 billion pre-tax project Net Present Value.
Read more here & follow BCN here:
ImmuPharma Rises over 7%
ImmuPharma (IMM) rose 7.5% this morning to 13.17p a share
The company is a specialist drug discovery and development company headquartered in London with research operations in France and Switzerland.
The company is focused on achieving the full regulatory approval of LupuzorTM which it believes has the potential to be a groundbreaking drug for lupus patients with “blockbuster potential in commercial terms”.
Read more here & follow IMM here:
See all today's AIM Risers here
